Results 291 to 300 of about 387,985 (305)

An update on the immune landscape in lung and head and neck cancers

Ca-A Cancer Journal for Clinicians, 2020
Jennifer W Carlisle, Conor Steuer, Taofeek Kunle Owonikoko   +2 more
exaly  

[Novel pharmacotherapies for recurrent pericarditis: interleukin-1 inhibitors].

Zhonghua xin xue guan bing za zhi, 2022
J X, Song, M, Zhao, J, Song, H, Chen
openaire   +1 more source

Interleukin 23 inhibitors for psoriasis: not just another number

Lancet, The, 2017
herve bachelez
exaly  

Interleukin-6: designing specific therapeutics for a complex cytokine

Nature Reviews Drug Discovery, 2018
Christoph Garbers, Sylvia Heink, Thomas Korn   +2 more
exaly  

Interleukin-21: a double-edged sword with therapeutic potential

Nature Reviews Drug Discovery, 2014
Warren J Leonard, Rosanne Spolski
exaly  

Treatment of rheumatoid tenosynovitis with cytokine inhibitors

Lancet, The, 2002
Abhilash Jain, Jagdeep Nanchahal
exaly  

Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial

Lancet, The, 2017
Peter Nash, Bruce W Kirkham, Proton Rahman   +2 more
exaly  

A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors

Ca-A Cancer Journal for Clinicians
Chadi Hage Chehade, Georges Gebrael, Nicolas Sayegh   +2 more
exaly  

Interleukin-1 Inhibitors and Their Significance in Rheumatoid Arthritis

2020
Gloria C. Higgins, Arnold E. Postlethwaite   +1 more
openaire   +1 more source

A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes

Nature, 1992
Keith O Elliston
exaly